Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Tomonori Akagi is a leading figure in colorectal cancer surgery and minimally invasive endoscopic techniques, with a career dedicated to advancing surgical oncology in Japan. His primary research focuses on optimizing surgical and adjuvant therapies for colorectal cancer, particularly through laparoscopic, robotic, and transanal approaches. Dr. Akagi’s major contributions include landmark studies on male sexual dysfunction following minimally invasive rectal cancer surgery, as demonstrated by the prospective LANDMARC study (8 citations), which provides critical insights into quality-of-life outcomes. He has also played a pivotal role in national-level assessments of endoscopic surgery, co-authoring the 16th National Survey of the Japan Society for Endoscopic Surgery (17 citations), which tracks the adoption and evolution of these techniques. During the COVID-19 pandemic, Dr. Akagi leveraged Japan’s National Clinical Database to evaluate the pandemic’s impact on elective surgeries, including laparoscopic distal gastrectomy and low anterior resection, with studies accumulating over 11 citations. His work on essential updates in colorectal cancer treatment (26 citations) underscores his influence in shaping clinical guidelines. With a career spanning over 100 publications and a citation count exceeding 500, Dr. Akagi is a trusted voice in surgical innovation and patient-centered outcomes.